CGBD
Carlyle Secured Lending, Inc.
CGBD's fundamentals are mixed, but it looks expensive: trading at 22x earnings, about twice its usual 10x. Analysts expect earnings to hold roughly steady.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
CGBD Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| N/A | |
| N/A |
CGBD's profitability is currently healthy, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like CGBD.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
CGBD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.5x | $2.84 | -75% |
| Forward | 7.6x | $11.18 | — |
| Fair | 10x | $5.27 | -53% |
| Expensive | 12x | $6.15 | -45% |
| Current | 22x | $11.18 | — |
Historical ranges are pointers, not guarantees.
CGBD's PE is in its expensive range at 22x. On analysts' estimates for next year's earnings, today's price would be 7.6x, in its cheap range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
CGBD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect CGBD's profitability to improve, with its earnings and revenue holding steady.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CGBD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.47 | +183% |
| Q3 2026 | $0.52 | -55% |
| Q2 2026 | $0.50 | -58% |
| Q1 2026 | $0.70 | -47% |
| Q4 2025 | $1.01 | -36% |
| Q3 2025 | $1.16 | -33% |
| Q2 2025 | $1.18 | -38% |
| Q1 2025 | $1.31 | -21% |
| Q4 2024 | $1.58 | -3.7% |
CGBD has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
CGBD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2022 | $15.8M | -70% |
| Q1 2022 | $40.4M | -10% |
| Q4 2021 | $43.7M | -9.4% |
| Q3 2021 | $57.5M | +32% |
| Q2 2021 | $52.5M | -23% |
| Q4 2020 | $48.2M | +15% |
IREN has the stronger quarterly revenue trend. Revenue is down 70% for CGBD versus down 5.1% for IREN.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | 31% | -51 points |
| Q1 2022 | 77% | -3.2 points |
| Q4 2021 | 79% | -0.6 points |
| Q3 2021 | 83% | +5.2 points |
| Q2 2021 | 82% | -0.8 points |
| Q1 2021 | 80% | N/A |
| Q4 2020 | 79% | +15 points |
| Q3 2020 | 78% | N/A |
CGBD's operating margin was 31% last quarter, down 51 points from the same quarter a year ago, near the bottom of its range since 2019.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
CGBD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $36.2M | +7.1% |
| Q2 2026 | $73.6M | +$304.5M |
| Q1 2026 | $212.4M | +46% |
| Q4 2025 | -$153.3M | -$42.1M |
| Q3 2025 | $33.8M | -46% |
| Q2 2025 | -$230.9M | -423% |
| Q1 2025 | $145.8M | +80% |
| Q4 2024 | -$111.1M | -299% |
CGBD has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
CGBD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -727K shares |
| 1 year | -5.6% | -4.1M shares |
| 3 years | +23% | +12.8M shares |
| 5 years | +16% | +9.6M shares |
| Available history | +17% | +10M shares |
CGBD has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6.1M |
| Q2 2026 | $12.5M |
| Q1 2026 | $18.5M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CGBD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 8.9x | High |
| Q1 2022 | 6.0x | High |
| Q4 2021 | 6.3x | High |
| Q3 2021 | 6.1x | High |
| Q2 2021 | 6.1x | High |
| Q1 2021 | 5.5x | High |
| Q4 2020 | 97.7x | High |
| Q4 2019 | 17.9x | High |
CGBD's net debt is about 8.9 years of its operating earnings (EBITDA), up from 6.1 years a year ago. Net leverage isn't a meaningful measure for financial services companies like CGBD.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
CGBD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.9 | Neutral |
| Stochastic | 50.2 | Neutral |
CGBD's weekly RSI is 52 (neutral) and its Stochastic is 50 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
CGBD PE vs Financial Services Sector
| Metric | CGBD | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 13x | 65% above |
| PE % | 90 | 63 | 27 pts above |
CGBD is trading at 22x earnings, a 65% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
CGBD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.8 | 3.9% above |
| 20 week MA | $10.9 | 2.6% above |
| 50 week MA | $11.4 | 1.5% below |
| 100 week MA | $13.1 | 15% below |
| 200 week MA | $14.4 | 22% below |
CGBD has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
CGBD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.2 | $11.1 | -22% |
| 2021 | $11.1 | $14.0 | +27% |
| 2022 | $14.0 | $14.8 | +5.2% |
| 2023 | $14.8 | $15.0 | +1.4% |
| 2024 | $15.0 | $18.3 | +22% |
| 2025 | $18.3 | $12.6 | -31% |
| 2026 YTD | $12.6 | $11.2 | -11% |
CGBD has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.